Ticker >

Omaxe share price

Omaxe Ltd.

NSE: OMAXE BSE: 532880 SECTOR: Construction - Real Estate  47k   66   7

90.65
+8.20 (9.95%)
BSE: 28 Mar 04:01 PM

Price Summary

Today's High

₹ 90.65

Today's Low

₹ 82

52 Week High

₹ 121.4

52 Week Low

₹ 42.39

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1657.99 Cr.

Enterprise Value

1776.64 Cr.

No. of Shares

18.29 Cr.

P/E

0

P/B

1.79

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  50.64

CASH

197.86 Cr.

DEBT

316.51 Cr.

Promoter Holding

74.14 %

EPS (TTM)

₹  -7.96

Sales Growth

11.6%

ROE

-17.39 %

ROCE

-9.55%

Profit Growth

-153.23 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year11.6%
3 Year-16.16%
5 Year-18.38%

Profit Growth

1 Year-153.23%
3 Year-136.24%
5 Year-224.92%

ROE%

1 Year-17.39%
3 Year-12.89%
5 Year-8.7%

ROCE %

1 Year-9.55%
3 Year-4.96%
5 Year0.92%

Debt/Equity

0.312

Price to Cash Flow

54.58

Interest Cover Ratio

-1.38212002671501

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 74.14 38.9
Sep 2023 74.14 38.9
Jun 2023 74.14 36.54
Mar 2023 74.14 48.23
Dec 2022 74.14 48.23
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 179.25 Cr.

 Limitations

  • The company has shown a poor profit growth of -136.2383274947% for the Past 3 years.
  • The company has shown a poor revenue growth of -16.1623316427349% for the Past 3 years.
  • Company has a poor ROE of -12.8916819550589% over the past 3 years.
  • Company has a poor ROCE of -4.95919014308136% over the past 3 years
  • Company has low Interest coverage ratio of -1.38212002671501.
  • Company has high debtor days of 197.43322667015.
  • Company has contingent liabilities of 1144.33 Cr.
  • The company has a low EBITDA margin of -3.77157480909798% over the past 5 years.
  • Promoter pledging is high as 38.9%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 142.36 166.11 150.04 166.12 220.64
Total Expenditure 161.74 205.25 147.54 161.9 227.81
Operating Profit -19.38 -39.14 2.5 4.22 -7.17
Other Income 4.74 4.8 3.59 1.27 2.41
Interest 25.75 26.34 27.61 26.17 29.11
Depreciation 14.11 13.11 12.31 9.14 12.63
Exceptional Items 0 0 0 0 0
Profit Before Tax -54.5 -73.79 -33.83 -29.82 -46.5
Tax -12.94 -15.79 -6.62 -5.93 -10.05
Profit After Tax -41.56 -58 -27.21 -23.89 -36.45
Adjusted EPS (Rs) -2.27 -3.17 -1.49 -1.31 -1.99

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 768.04 779.59 252.39 411.65 459.39
Total Expenditure 655.52 625.75 357.8 368.05 560.77
Operating Profit 112.52 153.84 -105.41 43.6 -101.38
Other Income 160.05 143.49 31.66 10.53 12.18
Interest 224.12 201.37 149.07 103.35 104.81
Depreciation 6.78 66.69 57.28 38.95 55.66
Exceptional Items 0 0 0 0 0
Profit Before Tax 41.67 29.27 -280.1 -88.17 -249.67
Provision for Tax 18.53 123.62 -69.89 -11.88 -56.48
Net Profit 23.14 -94.35 -210.21 -76.29 -193.19
Adjusted EPS (Rs.) 1.27 -5.16 -11.49 -4.17 -10.56

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 182.9 182.9 182.9 182.9 182.9
Total Reserves 1406.96 1308.41 1098.91 1025.04 831.5
Borrowings 431.18 409.53 394.39 256.29 196.22
Other N/C liabilities -133.58 117.19 -21.38 -62.27 -195.36
Current liabilities 4301.97 4048.17 4171.09 4245.9 4535.46
Total Liabilities 6189.43 6066.2 5825.91 5647.86 5550.72
Assets
Net Block 504.43 653.25 590.6 545.01 508.5
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 289.87 294.04 294.19 295.07 336.36
Loans & Advances 189.26 204.48 197.67 150.61 125.53
Other N/C Assets 19.93 20.67 20.32 35.32 45.48
Current Assets 5185.94 4893.76 4723.13 4621.85 4534.85
Total Assets 6189.43 6066.2 5825.91 5647.86 5550.72
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 41.67 29.27 -280.1 -88.17 -249.67
Adjustment 148.26 193.62 245.84 180.81 238.12
Changes in Assets & Liabilities 99.68 87.14 85.84 65.5 15.84
Tax Paid -18.19 -17.06 3.09 -14.1 26.09
Operating Cash Flow 271.42 292.97 54.67 144.04 30.38
Investing Cash Flow 136.4 33.6 298.84 228.04 268.02
Financing Cash Flow -426.04 -347.95 -334.33 -352.7 -312.28
Net Cash Flow -18.22 -21.38 19.18 19.38 -13.88

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 74.14 74.14 74.14 74.14 74.14
dream home developers pri... 4.88 4.88 4.88 4.88 4.88
guild builders private li... 63.57 63.57 63.57 63.57 63.57
jai bhagwan goel 0.55 0.55 0.55 0.55 0.55
jatin goel - - 0.84 0.84 0.84
mohit goel - - 0.84 0.84 0.84
rekha goel 0.49 0.49 0.49 0.49 0.49
rohtas goel 1.50 1.50 0.66 0.66 0.66
rohtas goel huf 0.01 0.01 0.01 0.01 0.01
seema goel 0.01 0.01 0.01 0.01 0.01
sunil goel 1.82 1.82 1.82 1.82 1.82
sunil goel huf 0.01 0.01 0.01 0.01 0.01
sushma goel 1.30 1.30 0.46 0.46 0.46
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 25.86 25.86 25.86 25.86 25.86
ajay upadhyaya - - - - 1.37
elara india opportunities... 2.13 2.13 2.13 2.13 2.13
investor education and pr... 0.06 0.06 0.06 - 0.07
life insurance corporatio... 2.58 2.29 2.29 2.29 2.29
llp 0.08 0.01 0.02 0.23 0.36
mgc fund limited 1.44 1.44 1.44 1.15 1.15
nomura singapore limited ... 3.95 3.82 3.82 2.94 2.90
investor education and pr... - - - 0.06 -
dishant milanbhai parikh - 1.21 1.35 - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • PresentationQ1FY21 30 Jul 2020

Company News

Omaxe acquires stake in M/s Secure Properties16 Mar 2024, 4:21PM Omaxe informs about disclosure 20 Feb 2024, 10:54AM Omaxe - Quaterly Results9 Feb 2024, 5:41PM Omaxe - Quaterly Results9 Feb 2024, 5:41PM Omaxe informs about disclosure25 Jan 2024, 10:06AM Omaxe informs about disclosure 24 Jan 2024, 10:30AM Omaxe acquires remaining 25% stake in ‘Omaxe World Street’8 Dec 2023, 9:28AM Omaxe acquires remaining 25% stake in subsidiary companies6 Dec 2023, 9:28AM Omaxe acquires stake in FBD Real Grow2 Dec 2023, 11:04AM Omaxe to invest close to Rs 4000 crore in Tier 2, Tier 3 cities20 Nov 2023, 11:43AM Omaxe - Quaterly Results9 Nov 2023, 4:44PM Omaxe informs about disclosure 7 Sep 2023, 10:29AM Omaxe - Quaterly Results10 Aug 2023, 5:32PM Omaxe - Quaterly Results10 Aug 2023, 5:32PM Omaxe incorporates associate company1 Jul 2023, 5:33PM Omaxe - Quaterly Results26 May 2023, 6:00PM Omaxe - Quaterly Results26 May 2023, 6:00PM Omaxe’s arm acquires entire stake in Salvatore Infra Buildtech20 Mar 2023, 9:37AM Omaxe - Quaterly Results13 Feb 2023, 5:15PM Omaxe - Quaterly Results13 Feb 2023, 5:15PM Omaxe incorporates step-down wholly owned subsidiary17 Dec 2022, 2:18PM Omaxe - Quaterly Results14 Nov 2022, 2:16PM Omaxe - Quaterly Results14 Nov 2022, 2:16PM Omaxe’s arm incorporates wholly owned subsidiary 12 Sep 2022, 5:26PM Omaxe bags project from DDA to develop sports complex, retail project in Dwarka 25 Aug 2022, 11:09AM Omaxe - Quaterly Results10 Aug 2022, 3:46PM Omaxe - Quaterly Results10 Aug 2022, 3:46PM Omaxe incorporates Wholly-Owned Subsidiary 25 Jul 2022, 3:29PM Omaxe incorporates wholly owned subsidiary company21 Jun 2022, 5:41PM Omaxe informs about acquisition21 Jun 2022, 4:12PM Omaxe incorporates wholly-owned subsidiary18 Jun 2022, 9:49AM OMAXE submits disclosures 11 Jun 2022, 12:15PM Omaxe partners with Jio-bp to set up EV charging and swapping infra10 Jun 2022, 11:28AM Omaxe incorporates wholly-owned subsidiary company 3 Jun 2022, 10:13AM Omaxe - Quaterly Results30 May 2022, 3:29PM Omaxe - Quaterly Results30 May 2022, 3:29PM Omaxe - Quaterly Results30 May 2022, 3:29PM Omaxe informs about disclosure7 May 2022, 9:53AM Omaxe raises Rs 440 crore from Varde Partners26 Apr 2022, 5:47PM Omaxe - Quaterly Results14 Feb 2022, 5:21PM Omaxe - Quaterly Results14 Feb 2022, 5:21PM Omaxe - Quaterly Results14 Feb 2022, 5:21PM Omaxe enters into concession agreement with Lucknow Development Authority31 Jan 2022, 10:46AM Omaxe informs about acquisition4 Jan 2022, 4:59PM Omaxe informs about newspaper publication 13 Nov 2021, 11:37AM Omaxe informs about disclosure21 Oct 2021, 9:37AM Omaxe sells properties worth Rs 2,051 crore in FY212 Jul 2021, 4:11PM Omaxe signs MOU with Honeywell Automation India23 Feb 2021, 2:37PM Omaxe witnesses more than double sales in 2019-207 Dec 2020, 3:23PM Omaxe informs about newspaper publication28 Nov 2020, 3:43PM

Omaxe Stock Price Analysis and Quick Research Report. Is Omaxe an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Omaxe has a PE ratio of -11.3786300405886 which is low and comparatively undervalued .

  • Share Price: - The current share price of Omaxe is Rs 90.55. One can use valuation calculators of ticker to know if Omaxe share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Omaxe has ROA of -3.450258872107 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Omaxe has a Current ratio of 0.999865504270791 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Omaxe has a ROE of -17.3861785325378 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Omaxe has a D/E ratio of 0.312 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Omaxe has an Inventory turnover ratio of 0.19883096619497 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Omaxe has reported revenue growth of 11.5972306571116 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Omaxe for the current financial year is -22.068395045604 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Omaxe is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Omaxe

Omaxe Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Omaxe Ltd. is a prominent real estate development company based in India. With a strong presence in North and Central India, the company has established itself as a leading player in the real estate industry. Omaxe is known for its expertise in residential, commercial, and integrated townships development.

Omaxe Ltd. - Share Price

Track the share price of Omaxe Ltd. using our pre-built screening tools. Stay updated with the latest market trends and analyze the performance of Omaxe stocks over time. Our tools provide real-time data and comprehensive insights for long-term stock investors seeking stock analysis.

Omaxe Ltd. - Balance Sheet

The balance sheet of Omaxe Ltd. reflects the company's financial position at a specific point in time. You can access the company's balance sheet on our website, along with other financial statements. For a detailed analysis, our premium features offer fair value calculation methods such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Omaxe Ltd. - Annual Report

The annual report of Omaxe Ltd. is a comprehensive document that provides detailed information about the company's performance, strategic initiatives, and financial health. Our website offers downloadable copies of the annual reports, allowing investors to study the company's progress and make informed investment decisions.

Omaxe Ltd. - Dividend

Stay updated on the dividend payouts of Omaxe Ltd. Our website provides information on dividend history, dividend yield, and other related data points. This allows investors to assess the company's dividend policy and evaluate its attractiveness as an investment option.

Omaxe Ltd. - Quarterly Result

Review the quarterly results of Omaxe Ltd. to analyze its financial performance and growth trajectory. Our platform offers access to the company's quarterly reports, enabling investors to gain insights into revenue, expenses, and other key financial metrics. Combine these reports with our premium features for a comprehensive analysis.

Omaxe Ltd. - Stock Price

Assess the stock price of Omaxe Ltd. and monitor its movement in the market with our tools. Stay informed about price fluctuations and identify potential investment opportunities. Make use of our pre-built screening tools to analyze historical data and patterns for a better understanding of the stock's performance.

Omaxe Ltd. - Price Chart

Track and analyze the price chart of Omaxe Ltd. Our website provides interactive and customizable price charts that allow investors to study historical stock prices and identify trends. Utilize this tool to make informed decisions based on technical analysis and market trends.

Omaxe Ltd. - News

Stay updated with the latest news and developments concerning Omaxe Ltd. Our platform features a dedicated news section that provides timely updates on the company's activities, partnerships, and industry-related news. Access to reliable information is crucial for long-term stock investors looking to conduct comprehensive stock analysis.

Omaxe Ltd. - Concall Transcripts

Access con-call transcripts of Omaxe Ltd. on our website. Con-call transcripts provide valuable insights into management discussions, strategies, and important announcements made during the conference calls. Study these transcripts to gain a deeper understanding of the company's operations and future plans.

Omaxe Ltd. - Investor Presentations

Investor presentations play a vital role in understanding a company's overall performance and growth strategy. Omaxe Ltd. offers investor presentations that outline its business model, key achievements, and future prospects. These presentations are available for download on our website, enabling investors to assess the company's potential as an investment opportunity.

Omaxe Ltd. - Promoters

Learn about the promoters of Omaxe Ltd. and their role in the company's growth and success. Understand the vision and values that drive the company forward. Studying the promoters' credentials and track record can provide valuable insights for long-term stock investors interested in Omaxe Ltd.

Omaxe Ltd. - Shareholders

Identify the major shareholders of Omaxe Ltd. and their stakes in the company. Shareholder analysis is crucial for understanding the ownership structure and potential influence on corporate decisions. Our platform provides information on the company's significant shareholders, aiding investors in their stock analysis process.

Investors looking for comprehensive stock analysis will find our website's pre-built screening tools, downloadable reports, and premium features highly beneficial. Access annual reports, con-call transcripts, investor presentations, credit ratings, and research reports to make informed investment decisions. Utilize our fair value calculation tools for optimal analysis, including DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. Explore the website thoroughly, gather relevant information, and conduct a thorough analysis to make informed investment decisions in Omaxe Ltd.

Read More
X